Bacterial Vaccines

"Bacterial Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease.

Descriptor ID	D001428
MeSH Number(s)	D20.215.894.135
Concept/Terms	Bacterial Vaccines Bacterial Vaccines Vaccine, Bacterial Bacterin Bacterial Vaccine Vaccines, Bacterial

Below are MeSH descriptors whose meaning is more general than "Bacterial Vaccines".

Chemicals and Drugs [D]
Complex Mixtures [D20]
Biological Products [D20.215]
Vaccines [D20.215.894]
Bacterial Vaccines [D20.215.894.135]

Below are MeSH descriptors whose meaning is related to "Bacterial Vaccines".

Below are MeSH descriptors whose meaning is more specific than "Bacterial Vaccines".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Bacterial Vaccines" by people in this website by year, and whether "Bacterial Vaccines" was a major or minor topic of these publications.

Bar chart showing 45 publications over 22 distinct years, with a maximum of 6 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	2	0	2
1997	0	1	1
1998	1	1	2
1999	3	2	5
2001	2	0	2
2005	1	0	1
2007	0	1	1
2009	1	0	1
2010	1	0	1
2011	2	0	2
2012	0	2	2
2013	1	1	2
2014	1	0	1
2015	0	1	1
2016	3	1	4
2017	2	0	2
2018	1	0	1
2019	4	2	6
2021	1	1	2
2022	0	2	2
2023	2	0	2
2024	1	1	2

Below are the most recent publications written about "Bacterial Vaccines" by people in Profiles.

Whelan AO, Flick-Smith HC, Walker NJ, Abraham A, Levitz SM, Ostroff GR, Oyston PCF. A glucan-particle based tularemia subunit vaccine induces T-cell immunity and affords partial protection in an inhalation rat infection model. PLoS One. 2024; 19(5):e0294998.

View in: PubMed
Vance DJ, Basir S, Piazza CL, Willsey GG, Haque HME, Tremblay JM, Rudolph MJ, Muriuki B, Cavacini L, Weis DD, Shoemaker CB, Mantis NJ. Single-domain antibodies reveal unique borrelicidal epitopes on the Lyme disease vaccine antigen, outer surface protein A (OspA). Infect Immun. 2024 Apr 09; 92(4):e0008424.

View in: PubMed
Gulati S, Mattsson AH, Schussek S, Zheng B, DeOliveira RB, Shaughnessy J, Lewis LA, Rice PA, Comstedt P, Ram S. Preclinical efficacy of a cell division protein candidate gonococcal vaccine identified by artificial intelligence. mBio. 2023 Dec 19; 14(6):e0250023.

View in: PubMed
Rudolph MJ, Davis SA, Haque HME, Ejemel M, Cavacini LA, Vance DJ, Willsey GG, Piazza CL, Weis DD, Wang Y, Mantis NJ. Structure of a transmission blocking antibody in complex with Outer surface protein A from the Lyme disease spirochete, Borreliella burgdorferi. Proteins. 2023 Nov; 91(11):1463-1470.

View in: PubMed
Frye AM, Ejemel M, Cavacini L, Wang Y, Rudolph MJ, Song R, Mantis NJ. Agglutination of Borreliella burgdorferi by Transmission-Blocking OspA Monoclonal Antibodies and Monovalent Fab Fragments. Infect Immun. 2022 09 15; 90(9):e0030622.

View in: PubMed
Lewis LA, Gulati S, Zelek WM, Morgan BP, Song WC, Zheng B, Nowak N, DeOliveira RB, Sanchez B, DeSouza Silva L, Schuurman J, Beurskens F, Ram S, Rice PA. Efficacy of an Experimental Gonococcal Lipooligosaccharide Mimitope Vaccine Requires Terminal Complement. J Infect Dis. 2022 05 16; 225(10):1861-1864.

View in: PubMed
Schiller ZA, Rudolph MJ, Toomey JR, Ejemel M, LaRochelle A, Davis SA, Lambert HS, Kern A, Tardo AC, Souders CA, Peterson E, Cannon RD, Ganesa C, Fazio F, Mantis NJ, Cavacini LA, Sullivan-Bolyai J, Hu LT, Embers ME, Klempner MS, Wang Y. Blocking Borrelia burgdorferi transmission from infected ticks to nonhuman primates with a human monoclonal antibody. J Clin Invest. 2021 06 01; 131(11).

View in: PubMed
Parzych EM, Gulati S, Zheng B, Bah MA, Elliott STC, Chu JD, Nowak N, Reed GW, Beurskens FJ, Schuurman J, Rice PA, Weiner DB, Ram S. Synthetic DNA Delivery of an Optimized and Engineered Monoclonal Antibody Provides Rapid and Prolonged Protection against Experimental Gonococcal Infection. mBio. 2021 03 16; 12(2).

View in: PubMed
Gulati S, Pennington MW, Czerwinski A, Carter D, Zheng B, Nowak NA, DeOliveira RB, Shaughnessy J, Reed GW, Ram S, Rice PA. Preclinical Efficacy of a Lipooligosaccharide Peptide Mimic Candidate Gonococcal Vaccine. mBio. 2019 11 05; 10(6).

View in: PubMed
Abraham A, Ostroff G, Levitz SM, Oyston PCF. A novel vaccine platform using glucan particles for induction of protective responses against Francisella tularensis and other pathogens. Clin Exp Immunol. 2019 11; 198(2):143-152.

View in: PubMed

People

Explore

Similar Concepts

Top Journals